Search tips
Search criteria 


Logo of pubhealthrepPublic Health Reports
Public Health Rep. 1996 Mar-Apr; 111(2): 152–156.
PMCID: PMC1381723

Statewide survey of laboratories performing Mycobacterium tuberculosis testing in Minnesota.


Rapid and accurate laboratory detection and identification of Mycobacterium tuberculosis, particularly multidrug-resistant strains, is critical to both public health control measures and patient management. The authors surveyed microbiology laboratories to evaluate whether their methods met national guidelines. As needed, laboratories received individualized recommendations for improvement. The laboratories were resurveyed a year later to assess changes in methods. Current guidelines recommend fluorochrome acid-fast smears, broth cultures, identification by nucleic acid probe or BACTEC-NAP, and BACTEC primary susceptibility panels, which should include pyrazinamide. Of 27 laboratories performing acid-fast smears, 15 used fluorochrome methods. Six of 16 laboratories performing mycobacterial cultures used broth media. Of six laboratories performing species identification, five used nucleic acid probes or BACTEC-NAP. Of five laboratories evaluating drug sensitivity, two used BACTEC and two included pyrazinamide in their protocols. Overall, 24 (89%) laboratories needed improvements; a year later, 16 (67%) of those had altered their methods or made definite plans to do so. Survey results suggest that health departments can facilitate improvements in laboratory testing for pathogens of public health importance.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR, Jr, Good RC. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol. 1993 Apr;31(4):767–770. [PMC free article] [PubMed]
  • Bloch AB, Cauthen GM, Onorato IM, Dansbury KG, Kelly GD, Driver CR, Snider DE., Jr Nationwide survey of drug-resistant tuberculosis in the United States. JAMA. 1994 Mar 2;271(9):665–671. [PubMed]
  • Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993 Feb 25;328(8):521–526. [PubMed]
  • Ellner JJ, Hinman AR, Dooley SW, Fischl MA, Sepkowitz KA, Goldberger MJ, Shinnick TM, Iseman MD, Jacobs WR., Jr Tuberculosis symposium: emerging problems and promise. J Infect Dis. 1993 Sep;168(3):537–551. [PubMed]
  • Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR, Jr, Good RC. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol. 1993 Apr;31(4):767–770. [PMC free article] [PubMed]
  • Cantwell MF, Snider DE, Jr, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA. 1994 Aug 17;272(7):535–539. [PubMed]
  • Snider DE, Jr, Roper WL. The new tuberculosis. N Engl J Med. 1992 Mar 5;326(10):703–705. [PubMed]
  • Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991 Oct;144(4):745–749. [PubMed]
  • Joseph S. Tuberculosis, again. Am J Public Health. 1993 May;83(5):647–648. [PubMed]
  • Starke JR, Jacobs RF, Jereb J. Resurgence of tuberculosis in children. J Pediatr. 1992 Jun;120(6):839–855. [PubMed]
  • Huebner RE, Good RC, Tokars JI. Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol. 1993 Apr;31(4):771–775. [PMC free article] [PubMed]

Articles from Public Health Reports are provided here courtesy of SAGE Publications